Liraglutide vs Nivolumab

## Liraglutide vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Liraglutide** and **Nivolumab**.

## Mechanism of Action

**Liraglutide**: GLP-1 receptor agonist enhancing insulin secretion.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Liraglutide — 13 hours; Nivolumab — 27 days.

## Chemical Properties

**Type**: Liraglutide — Protein; Nivolumab — Antibody.